Answer
Starting Acarizax is contraindicated in patients with FEV₁ below 70% of predicted value after adequate pharmacological treatment at initiation, or a severe asthma exacerbation within the last 3 months.
Sources for this answer
- ACARIZAX 12 SQ-HDMALK-Abello Ltd · emc · SmPC §4.3 Contraindications · Version 5Document updated
Sources checked